title: CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia.
authors.forename: C S
authors.initials: CS
authors.lastname: Chim
authors.forename: J S
authors.initials: JS
authors.lastname: Lau
authors.forename: K F
authors.initials: KF
authors.lastname: Wong
authors.forename: Y L
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D050762:Cyclin-Dependent Kinase Inhibitor p15 / Q000235:genetics*; D019175:DNA Methylation; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate
chemical_list: C493966:CDKN2B protein, human; D050762:Cyclin-Dependent Kinase Inhibitor p15